Growth Metrics

Dexcom (DXCM) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -2.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -16.93%
Dec 31, 2025 52.97%
Sep 30, 2025 -5.62%
Jun 30, 2025 24.00%
Mar 31, 2025 30.91%
Dec 31, 2024 15.09%
Sep 30, 2024 93.56%
Jun 30, 2024 -36.08%
Mar 31, 2024 38.67%
Dec 31, 2023 168.18%
Sep 30, 2023 -168.24%
Jun 30, 2023 20.71%
Mar 31, 2023 -50.80%
Dec 31, 2022 -27.21%
Sep 30, 2022 36.72%
Jun 30, 2022 39.03%
Mar 31, 2022 -72.54%
Dec 31, 2021 -162.34%
Sep 30, 2021 84.73%
Jun 30, 2021 62.25%
Mar 31, 2021 -93.86%
Dec 31, 2020 -179.43%
Sep 30, 2020 36.66%
Jun 30, 2020 -135.58%
Mar 31, 2020 100.85%
Dec 31, 2019 -75.99%
Sep 30, 2019 -185.17%
Jun 30, 2019 -305.35%
Mar 31, 2019 139.42%
Dec 31, 2018 64.27%
Sep 30, 2018 41.06%
Jun 30, 2018 -181.09%
Mar 31, 2018 15.91%
Dec 31, 2017 38.37%
Sep 30, 2017 -112.76%
Jun 30, 2017 -177.31%
Mar 31, 2017 -70.73%
Dec 31, 2016 -232.02%
Sep 30, 2016 -131.90%
Jun 30, 2016 -52.89%
Mar 31, 2016 -42.42%
Dec 31, 2015 -57.73%
Sep 30, 2015 -53.67%
Jun 30, 2015 -45.67%
Mar 31, 2015 -61.52%
Dec 31, 2014 -10.59%
Sep 30, 2014 28.97%
Jun 30, 2014 53.23%
Mar 31, 2014 -38.11%
Dec 31, 2013 26.50%
Sep 30, 2013 -38.55%